Loading…
Production of recombinant xenotransplantation antigen in Escherichia coli
The synthesis of sufficient amounts of oligosaccharides is the bottleneck for the study of their biological function and their possible use as drug. As an alternative for chemical synthesis, we propose to use Escherichia coli as a “living factory.” We have addressed the production of the Gal pα(1–3)...
Saved in:
Published in: | Biochemical and biophysical research communications 2003-03, Vol.302 (3), p.620-624 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The synthesis of sufficient amounts of oligosaccharides is the bottleneck for the study of their biological function and their possible use as drug. As an alternative for chemical synthesis, we propose to use
Escherichia coli as a “living factory.” We have addressed the production of the Gal
pα(1–3)Gal
pβ(1–4)GlcNAc epitope, the major porcine antigen responsible for xenograft rejection. An
E. coli strain was generated which simultaneously expresses NodC (to provide the chitin-pentaose acceptor), β(1–4) galactosyltransferase LgtB, and bovine α(1–3) galactosyltransferase GstA. This strain produced 0.68
g/L of the heptasaccharide Gal
pα(1–3)Gal
pβ(1–4)(GlcNAc)
5, which harbours the xenoantigen at its non-reducing end, establishing the feasibility of this approach. |
---|---|
ISSN: | 0006-291X 1090-2104 |
DOI: | 10.1016/S0006-291X(03)00227-4 |